Back
Camden Property Trust 10K Form
Buy
58
CPT
Camden Property Trust
Last Price:
98.09
Seasonality Move:
3.68%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2023-10-27 | 10Q | CPT/Camden Property Trust Quarterly |
2023-08-04 | 10Q | CPT/Camden Property Trust Quarterly |
2023-04-28 | 10Q | CPT/Camden Property Trust Quarterly |
2022-10-28 | 10Q | CPT/Camden Property Trust Quarterly |
2022-07-29 | 10Q | CPT/Camden Property Trust Quarterly |
2022-04-29 | 10Q | CPT/Camden Property Trust Quarterly |
Receive CPT News And Ratings
See the #1 stock for the next 7 days that we like better than CPT
CPT Financial Statistics
Sales & Book Value
Annual Sales: | $1.54B |
---|---|
Cash Flow: | $75.37M |
Price / Cash Flow: | 27.8 |
Annual Sales: | $46.64 |
Price / Book: | 2.1 |
Profitability
EPS (TTM): | 3.70000 |
---|---|
Net Income (TTM): | $403.31M |
Gross Margin: | $957.68M |
Return on Equity: | 8.05% |
Return on Assets: | 4.34% |
Camden Property Trust Earnings Forecast
Key Camden Property Trust Financial Ratios
- The Gross Profit Margin over the past 14 years for CPT is 62.11%.
- The Selling, General & Administrative Expenses for CPT have been equal to 4.05% of Gross Profit Margin.
- The Interest Expense is 33.08% of Operating Income.
- The Net Earning history of CPT is 26.15% of Total Revenues.
- Per Share Earnings over the last 31 years have been positive in 17 years.
Camden Property Trust Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Residential REITs |
Sector: | Real Estate |
Current Symbol: | CPT |
CUSIP: | 133131 |
Website: | camdenliving.com |
Debt
Debt-to-Equity Ratio: | 0.75 |
---|---|
Current Ratio: | 0.65 |
Quick Ratio: | 0.63 |
Price-to-Earnings
Trailing P/E Ratio: | 26.51 |
---|---|
Forward P/E Ratio: | 52.19 |
CPT Technical Analysis vs Fundamental Analysis
Buy
58
Camden Property Trust (CPT)
is a Buy
Is Camden Property Trust a Buy or a Sell?
-
Camden Property Trust stock is rated a Buy
The current Camden Property Trust [CPT] share price is $98.07. The Score for CPT is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.